GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5)

 MACC1_HUMAN             Reviewed;         852 AA.
Q6ZN28; A8MUS5; B2RNR9; Q6ZQN8; Q7Z5A5;
08-APR-2008, integrated into UniProtKB/Swiss-Prot.
08-APR-2008, sequence version 2.
16-JAN-2019, entry version 111.
RecName: Full=Metastasis-associated in colon cancer protein 1;
AltName: Full=SH3 domain-containing protein 7a5;
Name=MACC1;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
SPECIFICITY.
TISSUE=Colon carcinoma, and Trachea;
PubMed=19098908; DOI=10.1038/nm.1889;
Stein U., Walther W., Arlt F., Schwabe H., Smith J., Fichtner I.,
Birchmeier W., Schlag P.M.;
"MACC1, a newly identified key regulator of HGF-MET signaling,
predicts colon cancer metastasis.";
Nat. Med. 15:59-67(2009).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-31; LEU-515
AND THR-804.
TISSUE=Tongue;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=12690205; DOI=10.1126/science.1083423;
Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
Kwasnicka D., Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z.,
Lu F., Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
Rahman N., Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F.,
Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
Bruns G.A.P., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
Kim H.-G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
Winsor E.J.T., Grzeschik K.-H., Teebi A., Minassian B.A., Kere J.,
Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W.,
Mural R.J., Adams M.D., Tsui L.-C.;
"Human chromosome 7: DNA sequence and biology.";
Science 300:767-772(2003).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=12853948; DOI=10.1038/nature01782;
Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
Waterston R.H., Wilson R.K.;
"The DNA sequence of human chromosome 7.";
Nature 424:157-164(2003).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Lung;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
INTERACTION WITH FASLG.
PubMed=19807924; DOI=10.1186/1471-2172-10-53;
Voss M., Lettau M., Janssen O.;
"Identification of SH3 domain interaction partners of human FasL
(CD178) by phage display screening.";
BMC Immunol. 10:53-53(2009).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
-!- FUNCTION: Acts as a transcription activator for MET and as a key
regulator of HGF-MET signaling. Promotes cell motility,
proliferation and hepatocyte growth factor (HGF)-dependent
scattering in vitro and tumor growth and metastasis in vivo.
{ECO:0000269|PubMed:19098908}.
-!- SUBUNIT: Interacts with FASLG. {ECO:0000269|PubMed:19807924}.
-!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19098908}.
Nucleus {ECO:0000269|PubMed:19098908}. Note=Mainly found in the
cytoplasm in non-metastasizing tumors.
-!- TISSUE SPECIFICITY: Preferentially expressed in metastasizing
tumors. {ECO:0000269|PubMed:19098908}.
-!- SEQUENCE CAUTION:
Sequence=BAC87646.1; Type=Erroneous initiation; Evidence={ECO:0000305};
Sequence=EAW93719.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AJ313524; CAC86408.1; -; mRNA.
EMBL; AK128850; BAC87646.1; ALT_INIT; mRNA.
EMBL; AK131400; BAD18547.1; -; mRNA.
EMBL; CH236948; EAL24276.1; -; Genomic_DNA.
EMBL; AC007001; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471073; EAW93719.1; ALT_SEQ; Genomic_DNA.
EMBL; BC137090; AAI37091.1; -; mRNA.
CCDS; CCDS5369.1; -.
RefSeq; NP_877439.3; NM_182762.3.
UniGene; Hs.598388; -.
ProteinModelPortal; Q6ZN28; -.
BioGrid; 131381; 8.
IntAct; Q6ZN28; 2.
STRING; 9606.ENSP00000328410; -.
iPTMnet; Q6ZN28; -.
PhosphoSitePlus; Q6ZN28; -.
BioMuta; MACC1; -.
DMDM; 182627616; -.
EPD; Q6ZN28; -.
jPOST; Q6ZN28; -.
MaxQB; Q6ZN28; -.
PaxDb; Q6ZN28; -.
PeptideAtlas; Q6ZN28; -.
PRIDE; Q6ZN28; -.
ProteomicsDB; 67968; -.
Ensembl; ENST00000332878; ENSP00000328410; ENSG00000183742.
Ensembl; ENST00000400331; ENSP00000383185; ENSG00000183742.
Ensembl; ENST00000589011; ENSP00000466864; ENSG00000183742.
GeneID; 346389; -.
KEGG; hsa:346389; -.
UCSC; uc003sus.5; human.
CTD; 346389; -.
DisGeNET; 346389; -.
EuPathDB; HostDB:ENSG00000183742.12; -.
GeneCards; MACC1; -.
H-InvDB; HIX0025430; -.
HGNC; HGNC:30215; MACC1.
HPA; CAB068194; -.
HPA; HPA020081; -.
HPA; HPA020103; -.
HPA; HPA029476; -.
MIM; 612646; gene.
neXtProt; NX_Q6ZN28; -.
OpenTargets; ENSG00000183742; -.
PharmGKB; PA164722150; -.
eggNOG; ENOG410IHUQ; Eukaryota.
eggNOG; ENOG410YRKQ; LUCA.
GeneTree; ENSGT00390000013151; -.
HOGENOM; HOG000015297; -.
InParanoid; Q6ZN28; -.
OMA; VCGHSYM; -.
OrthoDB; 140316at2759; -.
PhylomeDB; Q6ZN28; -.
TreeFam; TF105572; -.
GenomeRNAi; 346389; -.
PRO; PR:Q6ZN28; -.
Proteomes; UP000005640; Chromosome 7.
Bgee; ENSG00000183742; Expressed in 99 organ(s), highest expression level in intestine.
Genevisible; Q6ZN28; HS.
GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
GO; GO:0005739; C:mitochondrion; IDA:HPA.
GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
GO; GO:0008083; F:growth factor activity; IEA:UniProtKB-KW.
GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
InterPro; IPR001452; SH3_domain.
InterPro; IPR000906; ZU5_dom.
Pfam; PF00791; ZU5; 1.
PROSITE; PS50002; SH3; 1.
PROSITE; PS51145; ZU5; 1.
1: Evidence at protein level;
Activator; Complete proteome; Cytoplasm; Growth factor; Mitogen;
Nucleus; Phosphoprotein; Polymorphism; Reference proteome; SH3 domain;
Transcription; Transcription regulation.
CHAIN 1 852 Metastasis-associated in colon cancer
protein 1.
/FTId=PRO_0000329032.
DOMAIN 212 349 ZU5. {ECO:0000255|PROSITE-
ProRule:PRU00485}.
DOMAIN 549 619 SH3. {ECO:0000255|PROSITE-
ProRule:PRU00192}.
MOD_RES 19 19 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
VARIANT 31 31 L -> V (in dbSNP:rs4721888).
{ECO:0000269|PubMed:14702039}.
/FTId=VAR_042620.
VARIANT 50 50 P -> L (in dbSNP:rs17142503).
/FTId=VAR_042621.
VARIANT 515 515 S -> L (in dbSNP:rs975263).
{ECO:0000269|PubMed:14702039}.
/FTId=VAR_042622.
VARIANT 728 728 E -> A (in dbSNP:rs12671170).
/FTId=VAR_042623.
VARIANT 804 804 R -> T (in dbSNP:rs3735615).
{ECO:0000269|PubMed:14702039}.
/FTId=VAR_042624.
CONFLICT 171 171 L -> P (in Ref. 2; BAD18547).
{ECO:0000305}.
CONFLICT 264 264 D -> N (in Ref. 2; BAD18547).
{ECO:0000305}.
CONFLICT 383 383 S -> N (in Ref. 2; BAD18547).
{ECO:0000305}.
SEQUENCE 852 AA; 96639 MW; 9272110E1F91489A CRC64;
MLITERKHFR SGRIAQSMSE ANLIDMEAGK LSKSCNITEC QDPDLLHNWP DAFTLRGNNA
SKVANPFWNQ LSASNPFLDD ITQLRNNRKR NNISILKEDP FLFCREIENG NSFDSSGDEL
DVHQLLRQTS SRNSGRSKSV SELLDILDDT AHAHQSIHNS DQILLHDLEW LKNDREAYKM
AWLSQRQLAR SCLDLNTISQ SPGWAQTQLA EVTIACKVNH QGGSVQLPES DITVHVPQGH
VAVGEFQEVS LRAFLDPPHM LNHDLSCTVS PLLEIMLGNL NTMEALLLEM KIGAEVRKDP
FSQVMTEMVC LHSLGKEGPF KVLSNCYIYK DTIQVKLIDL SQVMYLVVAA QAKALPSPAA
TIWDYIHKTT SIGIYGPKYI HPSFTVVLTV CGHNYMPGQL TISDIKKGGK NISPVVFQLW
GKQSFLLDKP QDLSISIFSC DPDFEVKTEG ERKEIKQKQL EAGEVVHQQF LFSLVEHREM
HLFDFCVQVE PPNGEPVAQF SITTPDPTPN LKRLSNLPGY LQKKEEIKSA PLSPKILVKY
PTFQDKTLNF SNYGVTLKAV LRQSKIDYFL EYFKGDTIAL LGEGKVKAIG QSKVKEWYVG
VLRGKIGLVH CKNVKVISKE QVMFMSDSVF TTRNLLEQIV LPLKKLTYIY SVVLTLVSEK
VYDWKVLADV LGYSHLSLED FDQIQADKES EKVSYVIKKL KEDCHTERNT RKFLYELIVA
LLKMDCQELV ARLIQEAAVL TSAVKLGKGW RELAEKLVRL TKQQMEAYEI PHRGNTGDVA
VEMMWKPAYD FLYTWSAHYG NNYRDVLQDL QSALDRMKNP VTKHWRELTG VLILVNSLEV
LRVTAFSTSE EV


Related products :

Catalog number Product name Quantity
EH1804 Metastasis-associated in colon cancer protein 1 Elisa Kit 96T
CSB-EL013298HU Human Metastasis-associated in colon cancer protein 1(MACC1) ELISA kit 96T
CSB-EL013298HU Human Metastasis-associated in colon cancer protein 1(MACC1) ELISA kit SpeciesHuman 96T
EIAAB46045 A domain-containing protein similar to matrilin and collagen,AMACO,AMACO,CCSP-2,Colon cancer secreted protein 2,Homo sapiens,Human,von Willebrand factor A domain-containing protein 2,VWA2
EIAAB37718 Cccap,Centrosomal colon cancer autoantigen protein,mCCCAP,Mouse,Mus musculus,Sdccag8,Serologically defined colon cancer antigen 8 homolog
5197 (IN) Metastasis associated in colon cancer 1 0.5 mg
5197 (IN) Metastasis associated in colon cancer 1 0.1 mg
MACOM MACC1 Gene metastasis associated in colon cancer 1
E81667Hu ELISA Kit for Metastasis Associated In Colon Cancer 1 (MACC1) 96T/Kit
E3698h Human Metastasis Associated In Colon Cancer 1 ELIS 96T
201-12-2996 Human Metastasis Associated In Colon Cancer 1(MACC1)ELISA Kit 96T
UB-E02795 Human Metastasis Associated In Colon Cancer 1(MACC1)ELISA Kit 96T
QY-E02795 Human Metastasis Associated In Colon Cancer 1(MACC1)ELISA Kit 96T
EIAAB37719 Antigen NY-CO-8,CCCAP,Centrosomal colon cancer autoantigen protein,hCCCAP,Homo sapiens,HSPC085,Human,SDCCAG8,Serologically defined colon cancer antigen 8
'CC05-11-005 Human Colon cancer tissue array (metastasis to liver or lymph nodes with normal live colon lymph nodes controls) tissues 10 x 7
SEM667Hu ELISA Kit for Metastasis Associated In Colon Cancer 1 (MACC1) Homo sapiens (Human) 96T
E81667Hu ELISA Kit for Metastasis Associated In Colon Cancer 1 (MACC1) Organism: Homo sapiens (Human) 96T
CO991 Colorectal (colon and rectum) cancer with matched lymph node metastasis tissue array, 44 cases_99 cores.
EIAAB25777 Homo sapiens,Human,KIAA0429,Metastasis suppressor protein 1,Metastasis suppressor YGL-1,MIM,Missing in metastasis protein,MTSS1
EIAAB30218 Mouse,Mus musculus,Pctpl,PCTP-L,PCTP-like protein,Sdccag28,Sdccagg28,Serologically defined colon cancer antigen 28 homolog,StARD10,Stard10,StAR-related lipid transfer protein 10,START domain-containin
EIAAB31146 140 kDa nuclear and cell adhesion-related phosphoprotein,Desmosome-associated protein,Domain-rich serine protein,DRS,DRS protein,DRSP,Homo sapiens,Human,Melanoma metastasis clone A protein,MEMA,Nuclea
CO992 Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases_99 cores
18-003-43778 Metastasis-associated protein MTA2 - Metastasis-associated 1-like 1; MTA1-L1 protein; p53 target protein in deacetylase complex Polyclonal 0.1 mg Protein A
18-003-44084 Metastasis-associated protein MTA2 - Metastasis-associated 1-like 1; MTA1-L1 protein; p53 target protein in deacetylase complex Polyclonal 0.1 mg Protein A
18-661-15114 Metastasis-associated protein MTA2 - Metastasis-associated 1-like 1; MTA1-L1 protein; p53 target protein in deacetylase complex Polyclonal 0.1 mg

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1689: Porphyrin and chlorophyll metabolism
WP1049: G Protein Signaling Pathways
WP1165: G Protein Signaling Pathways
WP1371: G Protein Signaling Pathways
WP1438: Influenza A virus infection
WP1493: Carbon assimilation C4 pathway
WP1502: Mitochondrial biogenesis
WP1531: Vitamin D synthesis
WP1566: Citrate cycle (TCA cycle)
WP1613: 1,4-Dichlorobenzene degradation
WP1616: ABC transporters
WP1624: Bacterial secretion system
WP1625: Base excision repair
WP1644: DNA replication
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1657: Glycerolipid metabolism
WP1659: Glycine, serine and threonine metabolism
WP1661: Glyoxylate and dicarboxylate metabolism
WP1663: Homologous recombination
WP1665: Limonene and pinene degradation
WP1672: Mismatch repair
WP1673: Naphthalene and anthracene degradation
WP1675: Nitrogen metabolism
WP1676: Non-homologous end-joining

Related Genes :
[SH3PXD2A FISH KIAA0418 SH3MD1 TKS5] SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains)
[env] Envelope glycoprotein gp160 (Env polyprotein) [Cleaved into: Surface protein gp120 (SU) (Glycoprotein 120) (gp120); Transmembrane protein gp41 (TM) (Glycoprotein 41) (gp41)]
[NCKIPSD AF3P21 SPIN90] NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein)
[Sh3pxd2a Fish Sh3md1 Tks5] SH3 and PX domain-containing protein 2A (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains)
[SH3RF1 KIAA1494 POSH POSH1 RNF142 SH3MD2] E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)
[SH3RF2 POSH3 POSHER PPP1R39 RNF158] E3 ubiquitin-protein ligase SH3RF2 (EC 2.3.2.27) (Heart protein phosphatase 1-binding protein) (HEPP1) (POSH-eliminating RING protein) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2)
[Sh3rf1 Posh Posh1 Sh3md2] E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)
[Sh3rf1 Kiaa1494 Posh Posh1 Sh3md2] E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2)
[SH3BP5 SAB] SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK)
[Sh3gl2 Sh3d2a Sh3p4] Endophilin-A1 (Endophilin-1) (SH3 domain protein 2A) (SH3 domain-containing GRB2-like protein 2) (SH3p4)
[ITSN2 KIAA1256 SH3D1B SWAP] Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein)
[SH3GL2 CNSA2 SH3D2A] Endophilin-A1 (EEN-B1) (Endophilin-1) (SH3 domain protein 2A) (SH3 domain-containing GRB2-like protein 2)
[SH3RF3 POSH2 SH3MD4] E3 ubiquitin-protein ligase SH3RF3 (EC 2.3.2.27) (Plenty of SH3s 2) (SH3 domain-containing RING finger protein 3) (SH3 multiple domains protein 4)
[ABI1 SSH3BP1] Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1)
[Abi1 Ssh3bp1] Abl interactor 1 (Abelson interactor 1) (Abi-1) (Ablphilin-1) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Spectrin SH3 domain-binding protein 1) (e3B1)
[FCHSD2 KIAA0769 SH3MD3] F-BAR and double SH3 domains protein 2 (Carom) (Protein nervous wreck 1) (NWK1) (SH3 multiple domains protein 3)
[SH3PXD2B FAD49 KIAA1295 TKS4] SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)
[Sh3pxd2b Fad49 Tks4] SH3 and PX domain-containing protein 2B (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains)
[Sh3rf2 Posh3 Posher Ppp1r39 Rnf158] E3 ubiquitin-protein ligase SH3RF2 (EC 2.3.2.27) (POSH-eliminating RING protein) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2)
[Fchsd2 Kiaa0769 Sh3md3] F-BAR and double SH3 domains protein 2 (Protein nervous wreck 1) (NWK1) (SH3 multiple domains protein 3)
[SH3KBP1 CIN85] SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1)
[SH3D19] SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP)
[Sh3kbp1 Ruk Seta] SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes)
[ASAP1 DDEF1 KIAA1249] Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)
[Sh3kbp1 Ruk Seta] SH3 domain-containing kinase-binding protein 1 (Regulator of ubiquitous kinase) (Ruk) (SH3-containing, expressed in tumorigenic astrocytes)
[Dbnl Abp1 Sh3p7] Drebrin-like protein (Actin-binding protein 1) (SH3 domain-containing protein 7)
[SH3GLB1 KIAA0491 CGI-61] Endophilin-B1 (Bax-interacting factor 1) (Bif-1) (SH3 domain-containing GRB2-like protein B1)
[Sh3rf2 Posh3 Ppp1r39 Rnf158] E3 ubiquitin-protein ligase SH3RF2 (EC 2.3.2.27) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2)
[SLC7A5 CD98LC LAT1 MPE16] Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter)
[RUSC1 NESCA] RUN and SH3 domain-containing protein 1 (New molecule containing SH3 at the carboxy-terminus) (Nesca)

Bibliography :
?>